GlycoMar is seeking investment to maximise the return from its R & D activities, by taking healthcare products to market, either directly or via out-licensing.
GlycoMar has created a proprietary technology platform for the discovery of glycobiology products with value in healthcare and personal care. Through this core activity the Company is able to generate early stage collaboration and licensing revenues, which reduce the overall requirement for investment.
We are currently seeking investment from Venture Capital funds and Business Angel syndicates, which will be applied in the development of two conusmer health care products.
Contact us for more information.